EPSILON-3 BIO LTD.
Epsilon-3 Bio Ltd. is a preclinical stage company with investment from Index Ventures, Novo Ventures and Imperial Innovations. The company is focused on the efficient development of first in class drug candidates stimulating safe removal of cellular debris. Such agents are expected to provide a useful treatment for a wide range of diseases including inflammation and autoimmunity, neurodegeneration, fibrosis and cancer.
EPSILON-3 BIO LTD.
Industry:
Biotechnology Pharmaceutical
Founded:
2010-01-01
Address:
Babraham, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.e3bio.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content Nginx Amazon CloudFront Google Adsense AWS Global Accelerator AdBlock Acceptable Ads
Similar Organizations
Delta 4
Delta 4 is a biotech startup driving the forefront of digital drug discovery and development.
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Inthera Bioscience
Inthera Bioscience is focused on developing inhibitors of intracellular protein interactions employing a proprietary technology platform.
Current Employees Featured
Founder
Investors List
Index Ventures
Index Ventures investment in Series A - Epsilon-3 Bio Ltd.
Imperial Innovations
Imperial Innovations investment in Series A - Epsilon-3 Bio Ltd.
Novo Ventures
Novo Ventures investment in Series A - Epsilon-3 Bio Ltd.
Official Site Inspections
http://www.e3bio.com
- Host name: 25.0.153.160.host.secureserver.net
- IP address: 160.153.0.25
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
